Trade SRPT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) is trading at US$17.10, down 3.88% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$1.98B. Over the past 52 weeks, SRPT has traded between US$14.68 and US$24.68. On Syfe you can trade SRPT with $0 commission and add it to your watchlist.
| Previous close | US$17.79 |
|---|---|
| Market cap | US$1.98B |
| P/E ratio | 16.32 |
| 52-week range | US$14.68 – US$24.68 |
| Volume | 9.79M |
| Exchange | US |
Sarepta Therapeutics, Inc. Common Stock (DE)
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
Year: 1997
Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says
Aug 6, 5:59 PM · MT Newswires
Oppenheimer Adjusts PT on Sarepta Therapeutics to $35 From $37, Maintains Outperform Rating
Aug 6, 1:59 PM · MT Newswires
-- Earnings Flash (SRPT) Sarepta Therapeutics, Inc. Posts Q2 Adjusted EPS $0.64 per Share
Aug 5, 8:35 PM · MT Newswires
Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) stock is trading at US$17.10, -3.88% from the previous close of US$17.79.
The market cap for Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) stock is approximately US$1.98B.
The price-to-earnings ratio for Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) is 16.32, based on the latest reported earnings.
The 52-week high for Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) stock is US$24.68.
The 52-week low for Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) stock is US$14.68.
Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) does not currently pay a dividend.
Stay on top of SRPT
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
